Researchers in the Biomedical Sciences Institute, Trinity College Dublin have led an international study identifying a remarkable drug that may be able to block multiple sclerosis and other inflammatory disease including arthritis, Alzheimer's, Parkinson's, gout, asthma and Muckle-Wells syndrome.
“This is exciting, one of the biggest discoveries we have had,” said Professor Luke O’Neill, the chairman of biochemistry based in the Trinity Biomedical Sciences Institute. “It is fantastic, the thing we have been looking for for 30 years. This could be the missing compound.”
MS Ireland will provide further updates of research study.